Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

Repisalud
Publicación Artículo científico (JournalArticle)

Viral Characteristics Associated with the Clinical Nonprogressor Phenotype Are Inherited by Viruses from a Cluster of HIV-1 Elite Controllers

  • Casado, Concepcion
  • Marrero-Hernández, Sara
  • Márquez-Arce, Daniel
  • Pernas, Maria
  • Marfil, Silvia
  • Borràs-Grañana, Ferran
  • Olivares, Isabel
  • Cabrera-Rodríguez, Romina
  • Valera, María-Soledad
  • de Armas-Rillo, Laura
  • Lemey, Philippe
  • Blanco, Julià
  • Valenzuela-Fernández, Agustín
  • Lopez-Galindez, Luis Cecilio
A small group of HIV-1-infected individuals, called long-term nonprogressors (LTNPs), and in particular a subgroup of LTNPs, elite controllers (LTNP-ECs), display permanent control of viral replication and lack of clinical progression. This control is the result of a complex interaction of host, immune, and viral factors. We identified, by phylogenetic analysis, a cluster of LTNP-ECs infected with very similar low-replication HIV-1 viruses, suggesting the contribution of common viral features to the clinical LTNP-EC phenotype. HIV-1 envelope (Env) glycoprotein mediates signaling and promotes HIV-1 fusion, entry, and infection, being a key factor of viral fitness in vitro, cytopathicity, and infection progression in vivo Therefore, we isolated full-length env genes from viruses of these patients and from chronically infected control individuals. Functional characterization of the initial events of the viral infection showed that Envs from the LTNP-ECs were ineffective in the binding to CD4 and in the key triggering of actin/tubulin-cytoskeleton modifications compared to Envs from chronic patients. The viral properties of the cluster viruses result in a defective viral fusion, entry, and infection, and these properties were inherited by every virus of the cluster. Therefore, inefficient HIV-1 Env functions and signaling defects may contribute to the low viral replication capacity and transmissibility of the cluster viruses, suggesting a direct role in the LTNP-EC phenotype of these individuals. These results highlight the important role of viral characteristics in the LTNP-EC clinical phenotype. These Env viral properties were common to all the cluster viruses and thus support the heritability of the viral characteristics.IMPORTANCE HIV-1 long-term nonprogressor elite controller patients, due to their permanent control of viral replication, have been the object of numerous studies to identify the factors responsible for this clinical phenotype. In this work, we analyzed the viral characteristics of the envelopes of viruses from a phylogenetic cluster of LTNP-EC patients. These envelopes showed ineffective binding to CD4 and the subsequent signaling activity to modify actin/tubulin cytoskeletons, which result in low fusion and deficient entry and infection capacities. These Env viral characteristics could explain the nonprogressor clinical phenotype of these patients. In addition, these inefficient env viral properties were present in all viruses of the cluster, supporting the heritability of the viral phenotype.
Repisalud
Publicación Artículo científico (JournalArticle)

HIV-1 envelope glycoproteins isolated from Viremic Non-Progressor individuals are fully functional and cytopathic

  • Cabrera-Rodríguez, Romina
  • Hebmann, Veronique
  • Marfil, Silvia
  • Pernas, Maria
  • Marrero-Hernández, Sara
  • Cabrera, Cecilia
  • Urrea, Víctor
  • Casado, Concepcion
  • Olivares, Isabel
  • Márquez-Arce, Daniel
  • Pérez-Yanes, Silvia
  • Estévez-Herrera, Judith
  • Clotet, Bonaventura
  • Espert, Lucile
  • Lopez-Galindez, Luis Cecilio
  • Biard-Piechaczyk, Martine
  • Valenzuela-Fernández, Agustín
  • Blanco, Julià
In untreated HIV-1-infected individuals, viremia is positively associated with disease progression. However, some viremic non progressors (VNPs) individuals show paradoxical high CD4+ T cell counts. HIV-1 envelope glycoprotein complex (Env) is a major cytopathic determinant in viral replication; therefore, we have deeply characterized Env function in this rare clinical phenotype. Full-length Env clones isolated from individuals with Viral Load (VL) > 10,000 copies/mL classified as VNPs (n = 15) or rapid progressors (RPs, n = 17) were geno- and phenotypically analyzed by determining diversity, expression, CD4 binding/signaling, fusogenicity, infectivity and autophagy induction. Selected Env clones from VNPs and RPs (n = 32) showed similar expression, fusion and infection abilities. Env clones from both groups showed similar affinity for CD4 during cell-to-cell transmission and consistently induced similar levels of CD4 signaling, measured by α-tubulin acetylation. Moreover, we demonstrate for the first time that primary Env clones from VNP and RP induce autophagy in uninfected cells and that this feature correlated with fusogenic capacity but was unrelated to disease progression. In conclusion, our data suggest that Env clones from VNP individuals are fully functional. Therefore, the paradoxical CD4+ T cell count stability coexisting with high levels of viral replication is unrelated to Env function.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Lack of concordance between residual viremia and viral variants driving de novo infection of CD4 + T cells on ART

  • Puertas, Maria C.|||0000-0002-6750-2318
  • Noguera-Julian, Marc|||0000-0002-6194-1395
  • Massanella, Marta|||0000-0002-3326-151X
  • Pou, Christian|||0000-0003-3932-788X
  • Buzón, Maria José|||0000-0003-4427-9413
  • Clotet Sala, Bonaventura|||0000-0003-3232-4598
  • Stevenson, Mario
  • Paredes, Roger|||0000-0002-6553-691X
  • Blanco, Julià|||0000-0002-2225-0217
  • Martínez Picado, Francisco Javier|||0000-0002-4916-2129
In most patients, current antiretroviral therapy (ART) regimens can rapidly reduce plasma viral load. However, even after years of effective treatment, a significant proportion of patients show residual plasma viremia below the clinical detection limit. Although residual viremia might be associated with increased chronic immune activation and morbidity, its origin and its potential role in the replenishment of the viral reservoir during suppressive ART is not completely understood. We performed an in-depth genetic analysis of the total and episomal cell-associated viral DNA (vDNA) repertoire in purified CD4 + T cell subsets of three HIV-infected individuals, and used phylogenetic analysis to explore its relationship with plasma viruses. The predominant proviral reservoir was established in naïve or memory (central and transitional) CD4 + T cell subsets in patients harboring X4- or R5-tropic viruses, respectively. Regardless of the viral tropism, most plasma viruses detected under suppressive ART resembled the proviral reservoir identified in effector and transitional memory CD4 + T-cell subsets in blood, suggesting that residual viremia originates from these cells in either blood or lymphoid tissue. Most importantly, sequences in episomal vDNA in CD4 + T-cells were not well represented in residual viremia. Viral tropism determines the differential distribution of viral reservoir among CD4 + T-cell subsets. In spite of viral tropism, the effector and transitional memory CD4 + T-cells subsets are the main source of residual viremia during suppressive ART, even though their contribution to the total proviral pool is small. However, the lack of concordance between residual viremia and viral variants driving de novo infection of CD4 + T cells on ART may reflect the predominance of defective plasma HIV RNA genomes. These findings highlight the need for monitoring the multiple viral RNA/DNA persistence markers, based on their differential contribution to viral persistence. The online version of this article (doi:10.1186/s12977-016-0282-9) contains supplementary material, which is available to authorized users.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Proteoliposomal formulations of an HIV-1 gp41-based miniprotein elicit a lipid-dependent immunodominant response overlapping the 2F5 binding motif

  • Molinos-Albert, Luis Manuel|||0000-0001-5447-6803
  • Bilbao, Eneritz
  • Agulló, Luis
  • Marfil, Sílvia|||0000-0003-0139-5000
  • García Rodríguez, Elisabet
  • Rodriguez de la Concepción, Maria Luisa|||0000-0002-6944-3462
  • Izquierdo Useros, Nuria|||0000-0002-1039-1821
  • Vilaplana Massaguer, Cristina|||0000-0002-2808-7270
  • Nieto-Garai, Jon A.
  • Contreras, F. Xabier
  • Floor, Martin
  • Cardona, Pere-Joan|||0000-0001-5623-7873
  • Martínez Picado, Francisco Javier|||0000-0002-4916-2129
  • Clotet Sala, Bonaventura|||0000-0003-3232-4598
  • Villà Freixa, Jordi|||0000-0002-6359-3929
  • Lorizate, Maier
  • Carrillo, Jorge|||0000-0003-0221-5948
  • Blanco, Julià|||0000-0002-2225-0217
The HIV-1 gp41 Membrane Proximal External Region (MPER) is recognized by broadly neutralizing antibodies and represents a promising vaccine target. However, MPER immunogenicity and antibody activity are influenced by membrane lipids. To evaluate lipid modulation of MPER immunogenicity, we generated a 1-Palmitoyl-2-oleoylphosphatidylcholine (POPC)-based proteoliposome collection containing combinations of phosphatidylserine (PS), GM3 ganglioside, holesterol (CHOL), sphingomyelin (SM) and the TLR4 agonist monophosphoryl lipid A (MPLA). A recombinant gp41-derived miniprotein (gp41-MinTT) exposing the MPER and a tetanus toxoid (TT) peptide that favors MHC-II presentation, was successfully incorporated into lipid mixtures (.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

An engineered HIV-1 Gag-based VLP displaying high antigen density induces strong antibody-dependent functional immune responses

  • Tarrés-Freixas, Ferran|||0000-0002-1569-0126
  • Aguilar-Gurrieri, Carmen|||0000-0002-5701-7650
  • Rodriguez de la Concepción, Maria Luisa|||0000-0002-6944-3462
  • Urrea, Víctor|||0000-0002-2577-856X
  • Trinité, Benjamin|||0000-0003-3809-042X
  • Ortiz, Raquel|||0000-0002-6919-2026
  • Pradenas, Edwards|||0000-0001-5162-8920
  • Blanco, Pau
  • Marfil, Sílvia|||0000-0003-0139-5000
  • Molinos-Albert, Luis Manuel|||0000-0001-5447-6803
  • Barajas Vélez, Ana|||0000-0003-1103-9499
  • Pons-Grífols, Anna|||0000-0002-8402-3941
  • Avila-Nieto, Carlos
  • Varela, Ismael|||0000-0002-3825-372X
  • Cervera Gracia, Laura|||0000-0002-3639-2793
  • Gutiérrez-Granados, Sònia
  • Segura, Maria Mercedes
  • Gòdia, Francesc|||0000-0002-4060-9887
  • Clotet Sala, Bonaventura|||0000-0003-3232-4598
  • Carrillo, Jorge|||0000-0003-0221-5948
  • Blanco, Julià|||0000-0002-2225-0217
Antigen display on the surface of Virus-Like Particles (VLPs) improves immunogenicity compared to soluble proteins. We hypothesised that immune responses can be further improved by increasing the antigen density on the surface of VLPs. In this work, we report an HIV-1 Gag-based VLP platform engineered to maximise the presence of antigen on the VLP surface. An HIV-1 gp41-derived protein (Min), including the C-terminal part of gp41 and the transmembrane domain, was fused to HIV-1 Gag. This resulted in high-density MinGag-VLPs. These VLPs demonstrated to be highly immunogenic in animal models using either a homologous (VLP) or heterologous (DNA/VLP) vaccination regimen, with the latter yielding 10-fold higher anti-Gag and anti-Min antibody titres. Despite these strong humoral responses, immunisation with MinGag-VLPs did not induce neutralising antibodies. Nevertheless, antibodies were predominantly of an IgG2b/IgG2c profile and could efficiently bind CD16-2. Furthermore, we demonstrated that MinGag-VLP vaccination could mediate a functional effect and halt the progression of a Min-expressing tumour cell line in an in vivo mouse model.